Literature DB >> 17890092

Prolonged interval between sentinel pseudotumoral demyelination and development of primary CNS lymphoma.

Steven Ng1, Helmut Butzkueven, Renate Kalnins, Christopher Rowe.   

Abstract

Primary central nervous system lymphoma (PCNSL) can be associated with preceding demyelinating pseudotumoral brain lesions. The 'sentinel' demyelinating lesions recede spontaneously or with corticosteroid, and are followed by development of PCNSL typically within 12 months. This report describes a 29 year-old post-partum woman who developed PCNSL 4 years after a biopsy-proven pseudotumoral demyelinating episode. She presented with focal seizures in February 2005. She subsequently developed hemiparesis and raised intracranial pressure. MRI showed two contrast enhancing lesions in the right frontal lobe, which were hypermetabolic on (18)F-FDG PET. A provisional diagnosis of tumefactive multiple sclerosis was made. Symptoms recurred despite multiple courses of high dose corticosteroid. Brain biopsy confirmed large B-cell non-Hodgkin's lymphoma. This patient illustrates the importance of considering PCNSL in patients presenting with a space-occupying lesion, even with previously confirmed demyelination, and that the interval between the two events may be several years.

Entities:  

Mesh:

Year:  2007        PMID: 17890092     DOI: 10.1016/j.jocn.2006.05.003

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  10 in total

1.  Recurrent tumefactive demyelination without evidence of multiple sclerosis or brain tumour.

Authors:  A Häne; M Bargetzi; E Hewer; M Bruehlmeier; A Khamis; U Roelcke
Journal:  J Neurol       Date:  2010-08-29       Impact factor: 4.849

2.  Tumefactive multiple sclerosis requiring emergent biopsy and histological investigation to confirm the diagnosis: a case report.

Authors:  So Yamada; Shoko Merrit Yamada; Hiroshi Nakaguchi; Mineko Murakami; Katsumi Hoya; Akira Matsuno; Kazuto Yamazaki; Yasuo Ishida
Journal:  J Med Case Rep       Date:  2012-04-06

3.  B cell-rich non-neoplastic sentinel lesion preceding primary central nervous system lymphoma.

Authors:  Rodrigo Javier; Nawal Shaikh; Maciej S Lesniak; Adam Sonabend; Roger Stupp; Amir Behdad; Craig Horbinski
Journal:  Diagn Pathol       Date:  2018-06-05       Impact factor: 2.644

4.  Lymphomatosis cerebri Presenting as a Recurrent Leukoencephalopathy.

Authors:  Floriane Courtois; Michel Gille; Frédéric Haven; Philippe Hantson
Journal:  Case Rep Neurol       Date:  2012-11-06

Review 5.  A challenging diagnosis of late-onset tumefactive multiple sclerosis associated to cervicodorsal syringomyelia: doubtful CT, MRI, and bioptic findings: Case report and literature review.

Authors:  Renata Conforti; Raffaella Capasso; Rosario Galasso; Mario Cirillo; Gemma Taglialatela; Luigi Galasso
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

6.  Demyelination as a harbinger of lymphoma: a case report and review of primary central nervous system lymphoma preceded by multifocal sentinel demyelination.

Authors:  Mark D Kvarta; Deva Sharma; Rudolph J Castellani; Robert E Morales; Stephen G Reich; Amy S Kimball; Robert K Shin
Journal:  BMC Neurol       Date:  2016-05-21       Impact factor: 2.474

Review 7.  Primary CNS Lymphomas: Challenges in Diagnosis and Monitoring.

Authors:  C Chiavazza; A Pellerino; F Ferrio; A Cistaro; R Soffietti; R Rudà
Journal:  Biomed Res Int       Date:  2018-06-21       Impact factor: 3.411

Review 8.  Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers.

Authors:  Matteo Bauckneht; Selene Capitanio; Stefano Raffa; Luca Roccatagliata; Matteo Pardini; Caterina Lapucci; Cecilia Marini; Gianmario Sambuceti; Matilde Inglese; Paolo Gallo; Diego Cecchin; Flavio Nobili; Silvia Morbelli
Journal:  EJNMMI Radiopharm Chem       Date:  2019-04-08

9.  Histopathological variation in the demyelinating sentinel lesion of primary central nervous system lymphoma.

Authors:  Madan Bajagain; Tatsuki Oyoshi; Tomoko Hanada; Nayuta Higa; Tsubasa Hiraki; Kiyohisa Kamimura; Shinichi Kuroki; Koji Yoshimoto
Journal:  Surg Neurol Int       Date:  2020-10-15

10.  Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG).

Authors:  Ramon F Barajas; Letterio S Politi; Nicoletta Anzalone; Heiko Schöder; Christopher P Fox; Jerrold L Boxerman; Timothy J Kaufmann; C Chad Quarles; Benjamin M Ellingson; Dorothee Auer; Ovidiu C Andronesi; Andres J M Ferreri; Maciej M Mrugala; Christian Grommes; Edward A Neuwelt; Prakash Ambady; James L Rubenstein; Gerald Illerhaus; Motoo Nagane; Tracy T Batchelor; Leland S Hu
Journal:  Neuro Oncol       Date:  2021-07-01       Impact factor: 12.300

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.